Skip to main content

Table 5 Mean values ± standard deviations and lower - upper 95% confidence levels of the DVH criteria for the different scenarios

From: Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy

Organ

DHV Metric (Acceptance Criteria)

Scenario 1

Scenario 2

Scenario 3

Scenario 4

Scenario 5

Bladder [%]

V75Gy (< 15%)

2.85 ± 4.44 (1.59-4.11)

3.88 ± 5.46 (2.33-5.44)

4.28 ± 6.04 (2.56-5.99)

7.81 ± 10.4 (4.87-10.76)

5.73 ± 7.82 (3.50-7.95)

V70Gy (< 20%)

9.19 ± 11.3 (5.97-12.41)

9.53 ± 11.6 (6.23-12.83)

9.64 ± 11.7 (6.31-12.98)

14.3 ± 12.7 (10.70-17.90)

10.2 ± 12.1 (6.75-13.61)

V65Gy (< 50%)

20.6 ± 13.6 (16.70-24.41)

21.9 ± 14.2 (17.84-25.91)

21.9 ± 14.1 (17.86-25.88)

25.4 ± 15.2 (21.08-29.69)

23.1 ± 14.2 (19.01-27.10)

V50Gy (< 50%)

34.0 ± 17.9 (28.87-39.07)

34.4 ± 18.0 (29.23-39.49)

34.4 ± 18.1 (29.29-39.55)

36.1 ± 18.6 (30.84-41.42)

34.9 ± 18.2 (29.72-40.05)

Rectum [%]

V70Gy (< 10%)

4.63 ± 4.98 (3.22-6.05)

5.1 ± 5.39 (3.57-6.63)

5.28 ± 5.58 (3.70-6.87)

7.83 ± 7.36 (5.74-9.92)

5.89 ± 6.12 (4.15-7.63)

V60Gy (< 30%)

18.4 ± 6.60 (16.55-20.31)

19.2 ± 6.60 (17.34-21.09)

19.4 ± 6.76 (17.43-21.27)

22.6 ± 7.07 (20.62-24.64)

20.2 ± 6.78 (18.32-22.17)

V50Gy (< 50%)

30.5 ± 8.81 (28.00-33.01)

31.1 ± 8.91 (28.59-33.66)

31.3 ± 9.07 (28.67-33.83)

34.0 ± 9.73 (31.20-36.73)

31.9 ± 9.22 (29.31-34.55)

V40Gy (< 70%)

41.4 ± 12.0 (37.97-44.80)

42.1 ± 12.3 (38.61-45.60)

42.2 ± 12.4 (38.72-45.75)

45.6 ± 13.7 (41.73-49.49)

43.1 ± 12.6 (39.46-46.65)

V30Gy (< 80%)

56.4 ± 17.0 (51.60-61.24)

56.3 ± 17.1 (51.45-61.17)

56.6 ± 17.2 (51.72-61.50)

60.8 ± 17.7 (55.80-65.87)

57.6 ± 17.3 (52.69-62.54)

Posterior rectal wall [%]

V50Gy (< 15%)

2.84 ± 3.01 (1.99-3.69)

3.10 ± 3.15 (2.21-4.00)

3.23 ± 3.32 (2.29-4.18)

4.94 ± 4.61 (3.63-6.25)

3.60 ± 3.59

(2.58-4.62)

V40Gy (< 30%)

12.2 ± 9.25 (9.59-14.85)

13.2 ± 9.92 (10.33-15.97)

13.3 ± 10.2 (10.43-16.22)

18.1 ± 13.7 (14.21-21.97)

14.4 ± 10.8 (11.30-17.44)

D2% (< 60Gy) [Gy]

49.0 ± 7.23 (46.95-51.06)

49.6 ± 7.16 (47.56-51.63)

49.7 ± 7.25 (47.63-51.75)

52.3 ± 7.31 (50.25-54.41)

50.4 ± 7.25 (48.30-52.42)

Femoral heads [%]

V50Gy (< 5%) le

0.66 ± 1.70 (0,17-1,14)

0.88 ± 2.26 (0,24-1,52)

1.05 ± 2.71 (0,28-1,83)

3.32 ± 6.72 (1,42-5,23)

1.49 ± 3.94 (0,37-2,61)

V50Gy (< 5%) ri

0.52 ± 1.26 (0,17-0,89)

0.76 ± 1.71 (0,28-1,25)

0.96 ± 2.12 (0,36-1,56)

3.61 ± 7.92 (1,36-5.86)

1.31 ± 3.02 (0,45-2,17)